Article Versions Notes

Chávez-Gutiérrez E, Martínez-Arellanes M, Murillo-López M, Medina-Guzmán MF, Mobarak-Richaud L, Pelcastre-Guzmán K, Quintana-Romero OJ, Ariza-Castolo A, Ayala-Moreno MdR, Salazar JR, et al. In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome. Pharmaceuticals. 2022; 15(12):1461. https://doi.org/10.3390/ph15121461

Chávez-Gutiérrez, Edwin, Matilda Martínez-Arellanes, Montserrat Murillo-López, María Fernanda Medina-Guzmán, Laila Mobarak-Richaud, Karen Pelcastre-Guzmán, Osvaldo Javier Quintana-Romero, Armando Ariza-Castolo, María del Rosario Ayala-Moreno, Juan Rodrigo Salazar, and et al. 2022. "In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome" Pharmaceuticals 15, no. 12: 1461. https://doi.org/10.3390/ph15121461

Chávez-Gutiérrez, E., Martínez-Arellanes, M., Murillo-López, M., Medina-Guzmán, M. F., Mobarak-Richaud, L., Pelcastre-Guzmán, K., Quintana-Romero, O. J., Ariza-Castolo, A., Ayala-Moreno, M. d. R., Salazar, J. R., Guerra-Araiza, C., Rodríguez-Páez, L., Pinto-Almazán, R., & Loza-Mejía, M. A. (2022). In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome. Pharmaceuticals, 15(12), 1461. https://doi.org/10.3390/ph15121461